Login to Your Account



China's Yifan acquires R&D biologics firm Generon for $180M

By Shannon Ellis
Staff Writer

Tuesday, December 20, 2016

SHANGHAI – Shanghai-based Generon Corp. Ltd. was acquired by the world's leading manufacturer of vitamin B5 API, Yifan Pharmaceutical Co. Ltd., a public company listed in Shenzhen.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription